Cargando…
Changes in Anti-SARS-CoV-2 IgG Subclasses over Time and in Association with Disease Severity
IgG is the most prominent marker of post-COVID-19 immunity. Not only does this subtype mark the late stages of infection, but it also stays in the body for a timespan of at least 6 months. However, different IgG subclasses have different properties, and their roles in specific anti-COVID-19 response...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143443/ https://www.ncbi.nlm.nih.gov/pubmed/35632683 http://dx.doi.org/10.3390/v14050941 |
_version_ | 1784715807488475136 |
---|---|
author | Korobova, Zoia R. Zueva, Elena V. Arsentieva, Natalia A. Batsunov, Oleg K. Liubimova, Natalia E. Khamitova, Irina V. Kuznetsova, Raisa N. Rubinstein, Artem A. Savin, Tikhon V. Stanevich, Oksana V. Kulikov, Alexandr N. Pevtsov, Dmitry E. Totolian, Areg A. |
author_facet | Korobova, Zoia R. Zueva, Elena V. Arsentieva, Natalia A. Batsunov, Oleg K. Liubimova, Natalia E. Khamitova, Irina V. Kuznetsova, Raisa N. Rubinstein, Artem A. Savin, Tikhon V. Stanevich, Oksana V. Kulikov, Alexandr N. Pevtsov, Dmitry E. Totolian, Areg A. |
author_sort | Korobova, Zoia R. |
collection | PubMed |
description | IgG is the most prominent marker of post-COVID-19 immunity. Not only does this subtype mark the late stages of infection, but it also stays in the body for a timespan of at least 6 months. However, different IgG subclasses have different properties, and their roles in specific anti-COVID-19 responses have yet to be determined. We assessed the concentrations of IgG1, IgG2, IgG3, and IgG4 against different SARS-CoV-2 antigens (N protein, S protein RBD) using a specifically designed method and samples from 348 COVID-19 patients. We noted a statistically significant association between severity of COVID-19 infection and IgG concentrations (both total and subclasses). When assessing anti-N protein and anti-RBD IgG subclasses, we noted the importance of IgG3 as a subclass. Since it is often associated with early antiviral response, we presumed that the IgG3 subclass is the first high-affinity IgG antibody to be produced during COVID-19 infection. |
format | Online Article Text |
id | pubmed-9143443 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91434432022-05-29 Changes in Anti-SARS-CoV-2 IgG Subclasses over Time and in Association with Disease Severity Korobova, Zoia R. Zueva, Elena V. Arsentieva, Natalia A. Batsunov, Oleg K. Liubimova, Natalia E. Khamitova, Irina V. Kuznetsova, Raisa N. Rubinstein, Artem A. Savin, Tikhon V. Stanevich, Oksana V. Kulikov, Alexandr N. Pevtsov, Dmitry E. Totolian, Areg A. Viruses Article IgG is the most prominent marker of post-COVID-19 immunity. Not only does this subtype mark the late stages of infection, but it also stays in the body for a timespan of at least 6 months. However, different IgG subclasses have different properties, and their roles in specific anti-COVID-19 responses have yet to be determined. We assessed the concentrations of IgG1, IgG2, IgG3, and IgG4 against different SARS-CoV-2 antigens (N protein, S protein RBD) using a specifically designed method and samples from 348 COVID-19 patients. We noted a statistically significant association between severity of COVID-19 infection and IgG concentrations (both total and subclasses). When assessing anti-N protein and anti-RBD IgG subclasses, we noted the importance of IgG3 as a subclass. Since it is often associated with early antiviral response, we presumed that the IgG3 subclass is the first high-affinity IgG antibody to be produced during COVID-19 infection. MDPI 2022-04-29 /pmc/articles/PMC9143443/ /pubmed/35632683 http://dx.doi.org/10.3390/v14050941 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Korobova, Zoia R. Zueva, Elena V. Arsentieva, Natalia A. Batsunov, Oleg K. Liubimova, Natalia E. Khamitova, Irina V. Kuznetsova, Raisa N. Rubinstein, Artem A. Savin, Tikhon V. Stanevich, Oksana V. Kulikov, Alexandr N. Pevtsov, Dmitry E. Totolian, Areg A. Changes in Anti-SARS-CoV-2 IgG Subclasses over Time and in Association with Disease Severity |
title | Changes in Anti-SARS-CoV-2 IgG Subclasses over Time and in Association with Disease Severity |
title_full | Changes in Anti-SARS-CoV-2 IgG Subclasses over Time and in Association with Disease Severity |
title_fullStr | Changes in Anti-SARS-CoV-2 IgG Subclasses over Time and in Association with Disease Severity |
title_full_unstemmed | Changes in Anti-SARS-CoV-2 IgG Subclasses over Time and in Association with Disease Severity |
title_short | Changes in Anti-SARS-CoV-2 IgG Subclasses over Time and in Association with Disease Severity |
title_sort | changes in anti-sars-cov-2 igg subclasses over time and in association with disease severity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143443/ https://www.ncbi.nlm.nih.gov/pubmed/35632683 http://dx.doi.org/10.3390/v14050941 |
work_keys_str_mv | AT korobovazoiar changesinantisarscov2iggsubclassesovertimeandinassociationwithdiseaseseverity AT zuevaelenav changesinantisarscov2iggsubclassesovertimeandinassociationwithdiseaseseverity AT arsentievanataliaa changesinantisarscov2iggsubclassesovertimeandinassociationwithdiseaseseverity AT batsunovolegk changesinantisarscov2iggsubclassesovertimeandinassociationwithdiseaseseverity AT liubimovanataliae changesinantisarscov2iggsubclassesovertimeandinassociationwithdiseaseseverity AT khamitovairinav changesinantisarscov2iggsubclassesovertimeandinassociationwithdiseaseseverity AT kuznetsovaraisan changesinantisarscov2iggsubclassesovertimeandinassociationwithdiseaseseverity AT rubinsteinartema changesinantisarscov2iggsubclassesovertimeandinassociationwithdiseaseseverity AT savintikhonv changesinantisarscov2iggsubclassesovertimeandinassociationwithdiseaseseverity AT stanevichoksanav changesinantisarscov2iggsubclassesovertimeandinassociationwithdiseaseseverity AT kulikovalexandrn changesinantisarscov2iggsubclassesovertimeandinassociationwithdiseaseseverity AT pevtsovdmitrye changesinantisarscov2iggsubclassesovertimeandinassociationwithdiseaseseverity AT totolianarega changesinantisarscov2iggsubclassesovertimeandinassociationwithdiseaseseverity |